Alterity Therapeutics (PRNAD) Acquisitions (2009 - 2015)

Alterity Therapeutics (PRNAD) posted quarterly Acquisitions of $20.9 million for Q4 2015, up 122.88% on a QoQ basis from $9.4 million in Q2 2011.

Alterity Therapeutics (PRNAD) Acquisitions (2009 - 2015) Analysis & Trends

Alterity Therapeutics (PRNAD) has reported Acquisitions for 4 consecutive years, with $20.9 million the latest figure, recorded in Q4 2015.

In Q4 2015, Acquisitions changed N/A year-over-year to $20.9 million; the TTM figure through Dec 2015 stood at $39.8 million (changed N/A YoY), while the FY2011 annual figure was $9.4 million, up 103.06% from the prior year.
Acquisitions came in at $20.9 million for Q4 2015 at Alterity Therapeutics, up from $9.4 million in the prior quarter.
The five-year high for Acquisitions was $20.9 million in Q4 2015, with the low at $9.4 million in Q2 2011.

Download Data